Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

VCEL is expected to report earnings to fall 86.22% to -3 cents per share on July 30

Q2'25

Est.

$-0.03

Q1'25

Missed

by $0.10

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.01

The last earnings report on May 08 showed earnings per share of -23 cents, missing the estimate of -13 cents. With 1.13M shares outstanding, the current market capitalization sits at 2.10B.

View a ticker or compare two or three

Compare

VCEL